Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00049218 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: Autologous dendritic cell-adenovirus p53 vaccine
DRUG: Carboplatin
DRUG: Etoposide

Sponsor

H. Lee Moffitt Cancer Center and Research Institute